Clintoria R. Williams, Ph.D.
Scientific Director of Cardio-Renal Institute, CRISP Director, and Associate Professor
Neuroscience, Cell Biology, and Physiology Department
Research Interests: Investigates renal mechanisms driving hypertension and kidney disease, aiming to improve cardio-renal health
Thomas L. Brown, Ph.D.
Professor and Associate Chair for Research
Neuroscience, Cell Biology, and Physiology Department
Research Interests: Investigates mechanisms linking pregnancy complications to hypertension and kidney disease, aiming to improve maternal health
Hongmei Ren, Ph.D.
Associate Professor and CRISP Co-Director
Biochemistry and Molecular Biology Department
Research Interests: Investigates mechanisms underlying cardiac dysfunction in muscular dystrophies to identify therapeutic targets to mitigate dystrophic pathology
Eric S. Bennett, Ph.D.
Professor and Chair of Neuroscience, Cell Biology, and Physiology; Interim Chair of Biochemistry and Molecular Biology
Neuroscience, Cell Biology and Physiology Department
Research Interests: Investigates cardiac electrical signaling in arrhythmias and heart failure, seeking novel therapeutic targets
David N. Dhanraj, MD
Associate Professor and Chair
Department of Obstetrics and Gynecology
Areas of Expertise: Focuses on maternal health disparities, studying hypertension and preeclampsia to improve outcomes for at-risk populations
Mark Oxman, D.O.
Nephrologist
Dayton Kidney and Boonshoft School of Medicine
Areas of Expertise: Focuses on nephrology, hypertension and dialysis, translating research into treatments for kidney disease
Khalid M. Elased, PharmD, Ph.D.
Professor
Pharmacology & Toxicology
Research Interests: Investigates urinary biomarkers associated with the renin–angiotensin system (RAS), with a particular emphasis on metabolic cardio-renal complications.
Courtney E.W. Sulentic, Ph.D.
Professor and Interim Associate Dean of Research-BSOM
Pharmacology and Toxicology
Research interests: Investigates mechanistic interactions between environmental exposures, genetics, and immune-based disease, aiming to identify therapeutic targets and define individual risk